Of note, most common p53 mutations not only impair its tumor-suppressor function (loss of function) but also confer novel pro-oncogenic potential on p53 (gain of function), which markedly enhances tumor progression and drug resistance [57]. This evidence concerns the gene TP53 and neoplasm.